Comparative study of HPV16 integration in cervical lesions between ethnicities with high and low rates of infection 
with high‑risk HPV and the correlation between integration rate and cervical neoplasia

Han,Lili; Maimaitiming,Tuerxunayi; Husaiyin,Sulaiya; Wang,Lin; Wusainahong,Kunduozi; Ma,Chunhua; Niyazi,Mayinuer

doi:10.3892/etm.2015.2740

Comparative study of HPV16 integration in cervical lesions between ethnicities with high and low rates of infection with high‑risk HPV and the correlation between integration rate and cervical neoplasia

Authors:
- Lili Han
- Tuerxunayi Maimaitiming
- Sulaiya Husaiyin
- Lin Wang
- Kunduozi Wusainahong
- Chunhua Ma
- Mayinuer Niyazi
View Affiliations

Affiliations: Postgraduate College of Xinjiang Medical University, Urumqi, Xinjiang 830011, P.R. China, Department of Gynecology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 830054, P.R. China
Published online on: September 10, 2015 https://doi.org/10.3892/etm.2015.2740
Pages: 2169-2174

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The etiology of a high incidence of cervical cancer in populations with a low human papillomavirus (HPV) infection rate is unclear. The current study aimed to investigate the role of HPV16 DNA integration in cervical lesions in women of Han and Uygur ethnicity and to explore the association between viral integration and a high cervical cancer morbidity with a low HPV infection rate. DNA was extracted from the biopsy specimens of cervical lesions of 379 patients of Uygur ethnicity and 464 patients of Han ethnicity, and multiple quantitative polymerase chain reaction (qPCR) assays were performed to determine the copy numbers of the HPV16 E2 and E6 genes. The copy number of the HPV16 DNA was evaluated according to the E2/E6 ratio. Among these cases, 122 Uygur and 121 Han specimens were found to be HPV16 positive. In the two populations, the percentage of cases with HPV16 integration (the sum of integrated‑type infection only or a mixture of free‑and integrated‑type infection) increased with the grade of the cervical lesions (P<0.001). Within groups with the same cervical lesion grade, no significant differences in HPV16 integration were found between women of Uygur and Han ethnicity (rank sum test, P>0.05). No significant differences in the distribution of the HPV16 integration rate according to lesion grade were found in either population (P>0.05). When the two subpopulations were considered as one sample population, the integration rate significantly increased with lesion grade (P=0.02). These results indicate that the integration rate of HPV16 E2 may serve as a molecular biological marker for the development of cervical lesions.

View Figures

View References

1	Cornelison TL: Humanpapillomavirus genotype 16 vaccine for cervical cancer prophylaxis and treatment. Cirr Opin Oncol. 12:466–473. 2000. View Article : Google Scholar
2	Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ and Meijer CJ: International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 348:518–527. 2003. View Article : Google Scholar : PubMed/NCBI
3	Pett M and Coleman N: Integration of high-risk human papillomavirus: A key event in cervical carcinogenesis? J Pathol. 212:356–367. 2007. View Article : Google Scholar : PubMed/NCBI
4	Jiang SQ, Tu SA, Zhou JL, Mai M, Bi J, Ru X, Sha L, Xu X, Hai R and Ai M: Investigation and analysis of gynecopathy in Cele county of Xinjiang, China. Zhongguo Fu You Bao Jian. 21:524–526. 2006.(In Chinese).
5	Li N and Dai M: Human papillomavirus in China: A multiple-centric cross sectional study. Zhonghua Ji Bing Kong Zhi Za Zhi. 12:411–415. 2008.(In Chinese).
6	Li L, Pan Q, Liu XF, Wu YP, Qiao YL, Ma Y, Chen F, Zhu K, Liu XW, RE Z, et al: A cross-sectional study: The prevalence and distribution characteristic of HPV infection in Uygur women in Xinjiang. Ai Zheng Jin Zhan. 2:114–118. 2010.(In Chinese).
7	Li J, Li LK, Ma JF, Wei LH, Niyazi M, Li CQ, Xu AD, Wang JB, Liang H, Belinson J and Qiao YL: Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China. Vaccine. 27:1210–1215. 2009. View Article : Google Scholar : PubMed/NCBI
8	Cricca M, Venturoli S, Leo E, Costa S, Musiani M and Zerbini M: Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions. J Virol Methods. 158:180–183. 2009. View Article : Google Scholar : PubMed/NCBI
9	Li W, Wang W, Si M, Han L, Gao Q, Luo A, Li Y, Lu Y, Wang S and Ma D: The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma. J Cancer Res Clin Oncol. 134:1355–1361. 2008. View Article : Google Scholar : PubMed/NCBI
10	Huang LW, Chao SL and Lee BH: Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis. J Clin Pathol. 61:627–631. 2008. View Article : Google Scholar : PubMed/NCBI
11	Matovina M, Sabol I, Grubisić G, Gasperov NM and Grce M: Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions. Gynecol Oncol. 113:120–127. 2007. View Article : Google Scholar
12	Tinelli A, Vergara D, Leo G, Malvasi A, Casciaro S, Leo E, Montinari MR, Maffia M, Marsigliante S and Lorusso V: Human papillomavirus genital infection in modern gynecology: Genetic and genomic aspects. Eur Clinics Obst Gynaecol. 3:1–6. 2007. View Article : Google Scholar
13	Arias-Pulido H, Peyton CL, Joste NE, Vargas H and Wheeler CM: Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol. 44:1755–1762. 2006. View Article : Google Scholar : PubMed/NCBI
14	Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R and Shah KV: International Biological Study on Cervical Cancer (IBSCC) Study Group: Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst. 87:796–802. 1995. View Article : Google Scholar : PubMed/NCBI
15	Pirami L, Giache V and Becciolini A: Analysis of HPV 16, 18, 31 and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. J Clin Pathol. 50:600–604. 1997. View Article : Google Scholar : PubMed/NCBI
16	Kalantari M, Blennow E, Hagmar B and Johansson B: Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn Mol Pathol. 10:46–54. 2001. View Article : Google Scholar : PubMed/NCBI
17	Kristiansen E, Jenkins A and Holm R: Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix. J Clin Pathol. 47:253–256. 1994. View Article : Google Scholar : PubMed/NCBI
18	Park JS, Hwang ES, Park SN, Ahn HK, Um SJ, Kim CJ, Kim SJ and Namkoong SE: Physical status and expression of HPV genes in cervical cancers. Gynecol Oncol. 65:121–129. 1997. View Article : Google Scholar : PubMed/NCBI
19	Dürst M, Kleinheinz A, Hotz M and Gissmann L: The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol. 66:1515–1522. 1985. View Article : Google Scholar : PubMed/NCBI
20	Wu XX, Niyazi M, Zhu KC, et al: Status of HPV16 infection in cervical lesions in Uygur women and its clinical significance. Zhong Guo Zhong Liu. 21:394–397. 2012.(In Chinese).
21	Zhang S, Cai HB and Ding XH: Different deletion states of HPV16 E2 gene in C-terminal hinge region and N-terminal in cervical lesions. Xiandai Fuchanke Jinzhan. 19:728–731. 2010.(In Chinese).
22	Saunier M, Monnier-Benoit S, Mauny F, Dalstein V, Briolat J, Riethmuller D, Kantelip B, Schwarz E, Mougin C and Prétet JL: Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identiﬁcation of hpv16-infected women with high-grade lesions or cervical carcinoma. J Clin Microbiol. 11:3678–3685. 2008. View Article : Google Scholar
23	Sathish N, Abraham P, Sridharan G, Shaji RV, Chandy G and Peedicayil A: E2 sequence variations of HPV 16 among patients with cervical neoplasia seen in the Indian subcontinent. Gynecol Oncol. 95:363–369. 2004. View Article : Google Scholar : PubMed/NCBI
24	Liu KJ, Liu Q and Tang HF: Study on genotypes of human papilloma virus infected Uigur and Han women with cervical cancer and their relationships with TERC gene amplification. Zhongguo Fuchanke Linchuang Zazhi. 6:449–452. 2008.(In Chinese).
25	Li HH: The study on the corralation between cervical cancer and HPV DNA integration, E2 disruption, ratio of HPV E2/E6. Zhongguo Mian Yi Xue Za Zhi. 26:670–673. 2010.(In Chinese).
26	Li Li, Mayinuer Niyazi, Wenhua Zhang, et al: A cross-section population study on different cervical cancer screening methods in uygur women of xinjiang. Zhongguo Zhongliu. 19:238–242. 2010.(In Chinese).
27	Zheng Y, Peng ZL, Lou JY and Wang H: Detection of HPV16 integration status in preinvasive and invasive cervical carcinoma. Zhongguo Kang Ai Xie Hui. 33:961–964. 2006.(In Chinese).
28	Shi YM, Ye H, Xiao CY, Chen JL, Wang YQ and Wu JF: Change and significance of HPV integrated state in cervical lesions. Shandong Yi Yao. 49:1–3. 2009.
29	Li KZ, Jin Z, Fang Y, Ai JH, et al: Study on the correlation between integrated state of HPV-16 and the occurrence of cervical cancer. Zhongguo Fu You Bao Jian. 26:4241–4244. 2011.(In Chinese).